Conformational landscape of non-B variants of HIV-1 protease: A pulsed EPR study

Biochem Biophys Res Commun. 2020 Nov 5;532(2):219-224. doi: 10.1016/j.bbrc.2020.08.030. Epub 2020 Aug 27.

Abstract

HIV infection is a global health epidemic with current FDA-approved HIV-1 Protease inhibitors (PIs) designed against subtype B protease, yet they are used in HIV treatment world-wide regardless of patient HIV classification. In this study, double electron-electron resonance (DEER) electron paramagnetic resonance (EPR) spectroscopy was utilized to gain insights in how natural polymorphisms in several African and Brazilian protease (PR) variants affect the conformational landscape both in the absence and presence of inhibitors. Findings show that Subtypes F and H HIV-1 PR adopt a primarily closed conformation in the unbound state with two secondary mutations, D60E and I62V, postulated to be responsible for the increased probability for closed conformation. In contrast, subtype D, CRF_AG, and CRF_BF HIV-1 PR adopt a primarily semi-open conformation, as observed for PI-naïve-subtype B when unbound by substrate or inhibitor. The impact that inhibitor binding has on shifting the conformational land scape of these variants is also characterized, where analysis provides classification of inhibitor induced shifts away from the semi-open state into weak, moderate and strong effects. The findings are compared to those for prior studies of inhibitor induced conformational shifts in PI-naïve Subtype B, C and CRF_AE.

Keywords: Conformational landscape; DEER; Flap distance; HIV-1 Protease; Natural polymorphisms; Non-B subtypes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Africa, Central
  • Brazil
  • Electron Spin Resonance Spectroscopy / methods
  • HIV Protease / chemistry*
  • HIV Protease / genetics*
  • HIV Protease / metabolism
  • HIV Protease Inhibitors / chemistry
  • HIV Protease Inhibitors / metabolism
  • HIV-1 / genetics
  • Polymorphism, Genetic
  • Protein Conformation
  • Spin Labels

Substances

  • HIV Protease Inhibitors
  • Spin Labels
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1